Skip to content
Mobidiag
Mobidiag
Enabling faster, more accessible molecular diagnostics
  • Home
  • Contact Us

Posts

Anaerobe, Volume 52, August 2018, Pages 111-114

August 15, 2018

Evaluation of a novel molecular assay to diagnose toxigenic strains of Clostridium difficile
Catherine Eckert,Thomas Devallière, Rabab Syed-Zaidia, Valérie Lalande, Frédéric Barbut.
Learn more about Amplidiag® C. difficile+027.

Share on: Share on FacebookShare on LinkedinShare on Twitter
Posted in: Publications

Post navigation

← Mobidiag Secures Additional Funding from Business Finland for Development of Rapid Sepsis Diagnostics Test Directly from Blood
International Symposium Salmonella and Salmonellosis (I3S) 2018, St. Malo, France →
  • Home
  • Contact Us
  • Cookie Policy (EU)


©2023 Hologic, Inc. All rights reserved.
Hologic, Mobidiag, Novodiag and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries. All other trademarks, registered trademarks, and product names are the property of their respective owners.
Learn more about our Privacy policy.
WordPress PopUp Top